Andrew Slade
Impact in
- Virology top 10%
- HIV Research and Treatment
-
- PARP inhibition in cancer therapy
- Cancer-related Molecular Pathways
Papers in
-
- CRISPR and Genetic Engineering 3
- DNA Repair Mechanisms 2
- Viral Infectious Diseases and Gene Expression in Insects 2
- Cancer therapeutics and mechanisms 2
- Genetics 6
- Virus-based gene therapy research 6
- Co-authors
- Peter C. Terry (1 shared paper)Michael A. Batey (2 shared papers)David R. Newell (2 shared papers)Niall M.B. Martin (2 shared papers)Nicola J. Curtin (2 shared papers)Caroline J. Richardson (2 shared papers)Yan Zhao (2 shared papers)Alan Lau (1 shared paper)
- Journals
- AIDS Research and Human Retroviruses (4 papers)Molecular Cancer Therapeutics (2 papers)Clinical Cancer Research (1 paper)Nature Biotechnology (1 paper)European Journal of Biochemistry (1 paper)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Andrew Slade
17 papers receiving 583 citations
Peers
Comparison fields: 5 of 76
- Virology 64
- Oncology 194
- Biotechnology 55
- Molecular Biology 362
- Genetics 137
Countries citing papers authored by Andrew Slade
This map shows the geographic impact of Andrew Slade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Slade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Slade more than expected).
Fields of papers citing papers by Andrew Slade
This network shows the impact of papers produced by Andrew Slade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Slade. The network helps show where Andrew Slade may publish in the future.
Co-authors
The 25 scholars most cited alongside Andrew Slade, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 124 | |
| 2 | 2012 | 109 | |
| 3 | 1995 | 79 | |
| 4 | 2005 | 79 | |
| 5 | 1992 | 48 | |
| 6 | 2001 | 42 | |
| 7 | 1991 | 33 | |
| 8 | 2000 | 28 | |
| 9 | 1991 | 20 | |
| 10 | 2008 | 20 | |
| 11 | 1993 | 8 | |
| 12 | 1997 | 6 | |
| 13 | 1995 | 5 | |
| 14 | 1995 | 5 | |
| 15 | 2004 | 4 | |
| 16 | 1999 | 1 | |
| 17 | Emerging platform bioprocesses for viral vectors and gene therapies | 2016 | 1 |
About Andrew Slade
Andrew Slade is a scholar working on Molecular Biology, Genetics, Virology, Oncology and Infectious Diseases, having authored 17 papers that have together received 612 indexed citations. Recurring topics across this work include Virus-based gene therapy research (6 papers), HIV Research and Treatment (5 papers), HIV/AIDS drug development and treatment (3 papers), CRISPR and Genetic Engineering (3 papers), DNA Repair Mechanisms (2 papers), Viral Infectious Diseases and Gene Expression in Insects (2 papers), Amino Acid Enzymes and Metabolism (2 papers) and Cancer therapeutics and mechanisms (2 papers). The work is most often cited by research in Virology (64 citations), Oncology (194 citations), Biotechnology (55 citations), Molecular Biology (362 citations) and Genetics (137 citations). Andrew Slade has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Peter C. Terry, Michael A. Batey, David R. Newell, Niall M.B. Martin, Nicola J. Curtin, Caroline J. Richardson, Yan Zhao, Alan Lau, Suzanne Kyle and Neil Almond. Their work appears in journals such as AIDS Research and Human Retroviruses, Molecular Cancer Therapeutics, Clinical Cancer Research, Nature Biotechnology and European Journal of Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.